Erik Lindgren
Overview
Explore the profile of Erik Lindgren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van de Munckhof A, Borhani-Haghighi A, Aaron S, Krzywicka K, Sanchez van Kammen M, Cordonnier C, et al.
Int J Stroke
. 2023 Jun;
18(9):1112-1120.
PMID: 37277922
Background: Adenovirus-based COVID-19 vaccines are extensively used in low- and middle-income countries (LMICs). Remarkably, cases of cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia (CVST-VITT) have rarely been...
12.
Lindgren E, Krzywicka K, de Winter M, Sanchez van Kammen M, Heldner M, Hiltunen S, et al.
Eur J Neurol
. 2023 May;
30(8):2305-2314.
PMID: 37165521
Background And Purpose: A prognostic score was developed to predict dependency and death after cerebral venous thrombosis (CVT) to identify patients for targeted therapy in future clinical trials. Methods: Data...
13.
Ranjan R, Ken-Dror G, Martinelli I, Grandone E, Hiltunen S, Lindgren E, et al.
Eur Stroke J
. 2023 Apr;
8(1):344-350.
PMID: 37021156
Background: Cerebral venous thrombosis (CVT) is an uncommon cause of stroke in young adults. We aimed to determine the impact of age, gender and risk factors (including sex-specific) on CVT...
14.
Krzywicka K, Aguiar de Sousa D, Cordonnier C, Bode F, Field T, Michalski D, et al.
Eur J Neurol
. 2023 Feb;
30(5):1335-1345.
PMID: 36773014
Background And Purpose: Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia (CVST-VITT) is an adverse drug reaction occurring after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. CVST-VITT...
15.
Altersberger V, Rusche N, Martinez-Majander N, Hametner C, Scheitz J, Henon H, et al.
Stroke
. 2022 Oct;
53(12):3557-3563.
PMID: 36252105
Background: The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely...
16.
van de Munckhof A, Lindgren E, Kleinig T, Field T, Cordonnier C, Krzywicka K, et al.
Stroke
. 2022 Sep;
53(10):3206-3210.
PMID: 36082668
Background: Cerebral venous thrombosis (CVT) due to vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe condition, with high in-hospital mortality rates. Here, we report clinical outcomes of patients with CVT-VITT...
17.
Woock M, Martinez-Majander N, Seiffge D, Selvik H, Nordanstig A, Redfors P, et al.
Ther Adv Neurol Disord
. 2022 Jul;
15:17562864221106362.
PMID: 35785404
The association between stroke and cancer is well-established. Because of an aging population and longer survival rates, the frequency of synchronous stroke and cancer will become even more common. Different...
18.
Scutelnic A, Krzywicka K, Mbroh J, van de Munckhof A, Sanchez van Kammen M, Aguiar de Sousa D, et al.
Ann Neurol
. 2022 Jun;
92(4):562-573.
PMID: 35689346
Objective: Cerebral venous thrombosis (CVT) caused by vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare adverse effect of adenovirus-based severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) vaccines. In March 2021, after...
19.
Krzywicka K, van de Munckhof A, Sanchez van Kammen M, Heldner M, Jood K, Lindgren E, et al.
Neurology
. 2021 Dec;
98(7):e759-e768.
PMID: 34921101
Background And Objectives: Cerebral venous sinus thrombosis (CVST) as a part of the thrombosis and thrombocytopenia syndrome is a rare adverse drug reaction of severe acute respiratory syndrome coronavirus disease...
20.
Lindgren E, Rentzos A, Hiltunen S, Serrano F, Heldner M, Zuurbier S, et al.
Eur J Neurol
. 2021 Nov;
29(3):761-770.
PMID: 34811840
Background And Purpose: To explore the prevalence, risk factors, time correlation, characteristics and clinical outcome of dural arteriovenous fistulas (dAVFs) in a cerebral venous thrombosis (CVT) population. Methods: We included...